Don't miss out on Thursday 31st October 2024, when IDEXX Laboratories (NASDAQ: IDXX) will disclose its third quarter financial results before market open. Investors will have the chance to learn more about the company's performance during the quarter.
the business is expected to report an estimated per share $2.68 profit for the quarter, as predicted by financial analysts on Wall Street. Furthermore, the company is anticipated to disclose a total revenue of $979.22 million during this period.
The company's earnings report for the corresponding quarter of the previous year showcased a per-share income of $2.53. This figure was a result of the company's total revenue, which reached an impressive $915.53 million during that specific period.
The company's yearly performance has been analyzed by Wall Street analysts, who have projected a total revenue of $3.92 billion. Additionally, they are expecting the company to achieve a per share profit of $10.56 for the fiscal year 2024.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $3.02 | +13.1% | 1.00 B | +6.4% |
| Q1 2024 | $2.81 | +10.2% | 964.10 M | +7.1% |
| Q4 2023 | $2.32 | +13.2% | 901.60 M | +8.8% |
| Q3 2023 | $2.53 | +17.7% | 915.53 M | +8.8% |
| Q2 2023 | $2.67 | +71.2% | 943.63 M | +9.7% |
| *Growth on year-over-year basis | ||||
Additionally, The company will host a conference call with investors and analysts on 31st October 2024 at 08:30 AM eastern time to review the Q3 2024 financial results.
IDEXX Laboratories (IDXX) closed Tuesday's regular trading session at $447.83, indicating a 0.36 percent fall. During the day, IDXX shares traded between $443.20 and $452.45, with a day volume of 702.80 thousand shares.
